Search results for Xtant Medical

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical Expands Triviumâ„¢ Portfolio with the Commercial Launch of Triviumâ„¢ Shaped

BELGRADE, Mont., May 6, 2026 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions…

Xtant Medical Reports First Quarter 2026 Financial Results

Raises full-year 2026 revenue guidance to a range of $101-$105 million Significantly strengthens balance sheet Enters into exclusive…

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical Holdings, Inc. reported financial and operating results for the first quarter ended March 31, 2026. The post Xtant Medical Reports First Quarter 2026 Financial Result...

Xtant Medical Expands Triviumâ„¢ Portfolio with the Commercial Launch of Triviumâ„¢ Shaped

Xtant Medical Holdings announced the commercial launch of Triviumâ„¢ Shaped, an extension of its Triviumâ„¢ bone graft portfolio . The post

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon’s HEMOBLAST® Bellows Produ...

Xtant has hired Dilon's U.S. sales team to assist in selling the HEMOBLAST® Bellows product and penetrating the estimated $2.0 billion global addressable market for hemostatic prod...

Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time

Tecomet and Orchid Complete Transaction, Creating a Scaled Global Manufacturing Platform

Medtronic announces CE Mark for Stealth AXiSв„ў surgical system

Axonics

Axonics Anonymous (not verified) Sun, 04/05/2026 - 17:00 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...

Biodynamik Receives FDA IDE Approval for Pivotal U.S. Trial of XT3 System in Diabetic Foot Ulcers

Theragen Receives First European Patent for ActaStimВ®-S

Tactile Medical projects $360M-$368M 2026 revenue as Medicare prior authorization process matures

VB Spine Completes Transaction of Augmented Reality Spine Platform from Augmedics

Theragen Receives First European Patent for ActaStim®-S

Company’s BGS Is Most Advanced Device in Categoryin More than Two Decades Jacksonville, FL, April 28, 2026 /OrthoSpineNews/…

Stereotaxis, Inc. (STXS) M&A Call Transcript

Axonics

Axonics Anonymous (not verified) Sat, 05/09/2026 - 08:22 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...

FDA-cleared. Quietly adopted. Nationally ready. KeyLiftâ„¢ is about to get loud.

FDA-cleared. Quietly adopted. Nationally ready. KeyLiftâ„¢ is about to get loud.

KeyLift Implants Amplio Spine, LLC signs Letter of Intent to acquire the FDA–cleared KeyLift™ Expandable Interlaminar Stabilization System (K232484)…

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

Amplify Surgical and Emory Healthcare Complete World’s First Continuously Navigated Endoscopic TLIF Using dualPort...

Boston Scientific: From Hypergrowth To Durable Compounding

Exagen (XGN) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DateMonday, May 11, 2026 at 8:30 a.m. ETCall participantsPresident & Chief Executive Officer — John AballiChief Financial Officer — Jeffrey Blac...

DePuy Synthes Announces Agreement to Acquire Miniature Radiofrequency Tracking Technology Across its Joint Reconstructio...